Principles of Genetic Counseling in the Era of Next- Generation Sequencing
2
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
Traditional genetic counseling has focused on the target gene and its natural progress with respect to disease risk. Next-generation sequencing (NGS) can produce information on several genetic variants simultaneously, with different functions and consequences for each. Accordingly, determining the status of the patient or consultant and interpreting sequencing results from many genes can largely increase the complexity of genetic counseling. Moreover, the current environment of big data that can be readily shared via the internet and a ubiquitous network provides many different avenues for which a consultant must handle the traditional principle of genetic counseling in different ways. Thus, further consideration and rethinking of genetic counseling principles are necessary in the era of NGS. In this review, we discuss several aspects of genetic counseling that one can encounter when faced with NGS data.
Abstract
Traditional genetic counseling has focused on the target gene and its natural progress with respect to disease risk. Next-generation sequencing (NGS) can produce information on several genetic variants simultaneously, with different functions and consequences for each. Accordingly, determining the status of the patient or consultant and interpreting sequencing results from many genes can largely increase the complexity of genetic counseling. Moreover, the current environment of big data that can be readily shared via the internet and a ubiquitous network provides many different avenues for which a consultant must handle the traditional principle of genetic counseling in different ways. Thus, further consideration and rethinking of genetic counseling principles are necessary in the era of NGS. In this review, we discuss several aspects of genetic counseling that one can encounter when faced with NGS data.
참고문헌 (24)
- Harper P, "Practical genetic counselling. 5th ed.", pp.3~4 (1998), Butterworth-Heinemann
- Vigorito E, "Fine-scale mapping at 9p22.2 identifies candidate causal variants that modify ovarian cancer risk in BRCA1 and BRCA2 mutation carriers", PLoS One, 11, pp.e0158801~ (2016)[DOI]
- Kalia SS, "Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics", Genet Med, 19, pp.249~255 (2017)[DOI]
- van El CG, "Whole-genome sequencing in health care: recommendations of the European Society of Human Genetics", Eur J Hum Genet, 21, pp.580~584 (2013)
- Park KS, "Comparative analysis of BRCA1 and BRCA2 variants of uncertain significance in patients with breast cancer: a multifactorial probability-based model versus ACMG standards and guidelines for interpreting sequence variants", Genet Med, 18, pp.1250~1257 (2016)[DOI]
- Ryu JM, "Suggestion of BRCA1 c.5339T>C (p.L1780P) variant confer from 'unknown significance' to 'Likely pathogenic' based on clinical evidence in Korea", Breast, 33, pp.109~116 (2017)[DOI]
- Schneider K, "Counseling about cancer: strategies for genetic counseling. 3rd ed.", pp.409~443 (2012), Wiley-Blackwell
- Resta R, "Genetic counseling practice: advanced concepts and skills", pp.22~ (2010), Wiley-Blackwell
- Wilson J, "To know or not to know? Genetic ignorance, autonomy and paternalism", Bioethics, 19, pp.492~504 (2005)[DOI]
- Andorno R, "The right not to know: an autonomy based approach", J Med Ethics, 30, pp.435~439 (2004)[DOI]
- Ndinya-Achola J, "The right not to know HIV-test results", Lancet, 345, pp.969~970 (1995)[DOI]
- Malpas P, "The right to remain in ignorance about genetic information--can such a right be defended in the name of autonomy?", N Z Med J, 118, pp.U1611~ (2005)
- Hofmann B, "Incidental findings of uncertain significance: To know or not to know-that is not the question", BMC Med Ethics, 17, pp.13~ (2016)[DOI]
- Robins Wahlin TB, "To know or not to know: a review of behaviour and suicidal ideation in preclinical Huntington's disease", Patient Educ Couns, 65, pp.279~287 (2007)[DOI]
- Shahmirzadi L, "Patient decisions for disclosure of secondary findings among the first 200 individuals undergoing clinical diagnostic exome sequencing", Genet Med, 16, pp.395~399 (2014)[DOI]
- Husted J, "The right to know and the right not to know", pp.24~37 (2014), Cambridge University Press
- Pergament D, "The legal past, present and future of prenatal genetic testing: professional liability and other legal challenges affecting patient access to services", J Clin Med, 3, pp.1437~1465 (2014)[DOI]
- Sparrow R, "Imposing genetic diversity", Am J Bioeth, 15, pp.2~10 (2015)[DOI]
- Review of ethical issues in medical genetics, "Wertz DC", World Health Organization Human Genetics Programme, 62~ (2003)
- Pichini A, "Experience with genetic counseling: the adolescent perspective", J Genet Couns, 25, pp.583~595 (2016)[DOI]
- Hehir-Kwa JY, "Towards a European consensus for reporting incidental findings during clinical NGS testing", Eur J Hum Genet, 23, pp.1601~1606 (2015)[DOI]
- Green RC, "ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing", Genet Med, 15, pp.565~574 (2013)[DOI]
- Hallowell N, "Revealing the results of wholegenome sequencing and whole-exome sequencing in research and clinical investigations: some ethical issues", J Med Ethics, 41, pp.317~321 (2015)[DOI]
- Laurino MY, "A report on ten Asia Pacific countries on current status and future directions of the genetic counseling profession: the establishment of the Professional Society of Genetic Counselors in Asia", J Genet Couns, pp.1~12 (2017)